SGS Colombia SAS, in collaboration with Ikänik Farms, completes the development of the GPTCP certification
CORONA, California, April 12, 2021 / PRNewswire / – Ikänik Farms, Inc. (CSE: IKNK.U) (“Ikänik Farms” or the “Company”) is pleased to announce Pideka SAS. (“Pideka”), a wholly-owned subsidiary of Ikänik Farms, has successfully entered into its collaboration agreement with SGS Colombia SAS (“SGS”) to design, initiate, develop and implement a normative standard for the international certification of medical cannabis. This certification sets a new basic standard for the quality and safety of pharmaceutical grade cannabis products known as “GPTCP” or “Good Production Transformation & Commercialization Practices Cannabis Pharma”.
“The completion of this certificate of cooperation with SGS Colombia is a milestone and a reflection of the company’s commitment to first-class quality for the cannabis industry.” said Brian Baca, CEO of Ikänik Farms.
Information on GPTCP certification
The GPTCP certificate ensures that the company complies with international standards and differentiates itself by complying with a global quality standard for the production of cannabis.
With the joint development of the SGS-certified seal for self-regulation and sustainability, industry-wide best practices are promoted and a competitive quality approach is promoted through first-class and standardized processes throughout the industry, which gives end-users the confidence in the products.
The GPTCP covers aspects of the requirements under various standards such as BPA, BPM, INVIMA, ICA, ISO 9001, SG-SST and EUGMP at national (Colombian) and international level.
Quality certification and delivery of high quality products is one of the main objectives of the company, which is supported by operational certifications for its business operations, including (GACP, GMP FARMA, ISO-9001 and EUGMP).
About SGS Colombia SAS
SGS Colombia SAS is a subsidiary of SGS SA, one of the world’s leading inspection, verification, testing and certification companies. SGS is recognized as the global benchmark for quality and integrity. With more than 97,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.
About Ikänik Farms
Ikänik Farms is a California-based Multinational Operator (MNO) building a dynamic portfolio of brands inspired by a passion for health and wellness, action sports, and backed by its vertically integrated retail, distribution and cultivation operations in and around California and medical grade laboratory in Colombia. The company management brings decades of know-how in the areas of research and development, cultivation, retail, branding and corporate finance. Ikänik Farms’ operations in Colombia have the Pideka pharmaceutical division with GMP-PHARMA and (GACP) Good Agricultural and Collection Practice certifications for the Casa Flores facility.
This press release contains “forward-looking information” and “forward-looking statements” within the meaning of Canadian and US securities laws (collectively, “forward-looking information”). All information other than statements of historical facts is included. This press release that deals with activities, events or developments that the company expects or expects to occur in the future is forward-looking information. In this press release, words such as “will,” “might,” “plan,” “estimate,” “expect,” “intend,” “may,” “potentially,” “believe,” “should” and similar expressions are used are forward-looking information.
Although the company has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking information, there may be other factors that could cause its results, performance or achievements not be as expected and estimated or intended, including, but not limited to: changes in the law, change in management, inability to obtain additional funding, increased competition, obstruction to market growth, and government acceptance due to inconsistent public opinion and perception medical use and adult use marijuana industry and regulatory or policy changes.
There can be no guarantee that this information will prove to be correct or that management’s expectations or estimates with regard to future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events projected in the forward-looking information could differ materially from actual results or events.
Accordingly, readers are cautioned not to place undue reliance on forward-looking information. The forward-looking information in this press release is as of the date of this press release. The company disclaims any intention or obligation to update or revise any such information except as required by law, and the company assumes no liability for the disclosure in relation to any other company mentioned herein.
On behalf of the Board of Directors of Ikänik Farms Inc.
SOURCE Ikanik Farms Inc.